Glooko announced today that it launched its Insulin Pump Settings Electronic Health Record (EHR) integration capability. Palo Alto, California-based Glooko says the first-of-its-kind capability within its latest software release visualizes critical insulin pump configuration data directly into the clinical workflow. The company says that visibility of pump settings provides essential clinical context for clinics caring […]
glooko
Glooko wins FDA clearance for cloud-based insulin dosing platform
Glooko announced today that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform. Palo Alto, California-based Glooko describes the EndoTool IV Cloud as the first FDA-cleared platform of its kind. The cloud-based version of EndoTool IV, it offers a clinical decision support solution for intravenous insulin dosing in […]
MyLife Diabetes Care, Glooko expand partnership
Glooko and MyLife Diabetes Care announced today that they agreed to expand their partnership centered around diabetes management products. Under their agreement, Glooko serves as MyLife Diabetes Care’s primary data management platform for MyLife products. Glooko offers diabetes management platforms such as EndoTool, a leading software platform that offers capabilities for inpatient insulin dosing and […]
Glooko data backs insulin dosing platform
Glooko announced new data reflecting positive outcomes using its EndoTool platform for insulin dosing. EndoTool, a leading software platform, offers capabilities for inpatient insulin dosing and glycemic management. The FDA-cleared platform delivers assistance in optimizing insulin dosing, using a patient-specific algorithm in real-time. It helps reduce the risk of hypoglycemia and helps hospitals meet CMS […]
Glooko integrates diabetes management tech with Roche CGM
Glooko announced today that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM. The integration enables users of the Roche continuous glucose monitor (CGM) to bring their data into Glooko alongside data from other connected diabetes and health monitoring devices, such as insulin pumps, wearables and more. This can reduce the […]
Glooko acquires Monarch Medical and its diabetes management tech
Glooko announced today that it acquired Monarch Medical Technologies, maker of the EndoTool glucose management system. EndoTool, a leading software platform, offers capabilities for inpatient insulin dosing and glycemic management. Glooko said its acquisition expands its connected care capabilities into inpatient glycemic management. This complements the company’s foundation in outpatient diabetes. The FDA-cleared platform delivers […]
Glooko adds chief strategy officer to chief medical officer’s title
Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer. Clements became the Palo Alto, California-based diabetes management company’s fractional chief medical officer in 2016. He now steps into an expanded, full-time role designed to integrate Glooko’s clinical vision, product roadmap and data solutions. […]
Glooko integrates diabetes management platform with Abbott FreeStyle Libre
Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U.S. The integration further strengthens Glooko’s commitment to offering a comprehensive, all-in-one solution for managing diabetes. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin […]
Glooko, Innovation Zed partner on digital companion apps for injection therapy management
Glooko and Innovation Zed today announced a strategic partnership to develop and deploy digital companion apps for injectable therapies. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. Ireland-based Innovation Zed develops insulin […]
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital therapeutic technologies. It aims to enhance access for people with type 1 and type 2 diabetes requiring advanced bolus insulin dosing support. The companies kicked off their launch in […]
